Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bearish
Joinn Laboratories China Lt
Watchlist
Joinn Laboratories (6127.HK) 22H1 - It's Time to Face Reality Before the Magic of Monkeys Disappears
Equity Bottom-Up
333 Views
29 Sep 2022 00:39
The logic chain of "monkey shortage-monkey price rise-Joinn’s performance increase" has shaken.Faced with doubts about future prosperity of CXO,Joinn isn't immune. It's hard to achieve V-shape rebound
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
South Korea
Japan
Event-Driven
Equity Bottom-Up
India
Equity Derivatives
China
Philippines
Singapore
Trending Insights
More »
Toyota Industries (6201 JP): Thoughts on Intrinsic Value
Foshan Haitian Flavouring & Food (3288 HK): Offering Details & Index Inclusion
Virgin Australia (VGN AU): Touch & Go for Index Inclusion
Kioxia IPO Lockup Expiry - US$6.7bn Release, with Shareholders Eager to Sell
MINISO (9896 HK)'s (Possible) TOP TOY Spin-Off Is Priced In
Top Unpaywalled Insights
More »
Bearishness Persist in Soybeans Despite Rebound Hopes
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
[IO Technicals 2025/23] Bearish Momentum Persists
VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
MicroPort NeuroTech (2172.HK) 22H1 - Advantages Deserve Recognition, but with Overvaluation Risk
06 Oct 2022
Shanghai United Imaging Healthcare (688271.CH) - Overvalued; Stock Price Will Return to Rationality
04 Oct 2022
China Healthcare Weekly (Sep.30) - Orthopedics VBP, CGT CDMO, Surgical Robots, Bottom of HKEX
02 Oct 2022
About the CXO Plunge After Biden Signed National Biotechnology and Biomanufacturing Initiative
19 Sep 2022
Wuxi Biologics (2269.HK) 2022H1 - Hard to Achieve V-Share Rebound
22 Aug 2022
Joinn Laboratories (6127.HK) - Concerns Begin to Arise when the Monkeys Become More Expensive
01 Dec 2021
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x